Clinical Trial Update: Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

View source ↗

Summary

This completed clinical trial reports clinical, virological and safety outcomes for a lopinavir/ritonavir-based regimen used in routine clinical practice in HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: Abbott | Conditions: HIV-1 Infections | Status: COMPLETED | Results posted: 2011-08-03